The pro-apoptotic effects of some anti-cancer drugs are highly interrelated to the inactivation of the PI3K/AKT pathway 16, thereby demonstrating that inhibiting the PI3K/AKT signaling cascade may act as an effective tumor treatment strategy. This evidence concerns the gene AKT1 and neoplasm.